7cups
-8%
est. 2Y upside i
7 Cups is an emotional support service that matches up people that…
Rank
#3774
Sector
HealthTech / Digital Health
Est. Liquidity
~6Y
Data Quality
Data: Low7 Cups presents a high-risk, low-liquidity equity proposition on a 2-year horizon.
Last updated: May 5, 2026
A large health platform (e.g., CVS Health, UnitedHealth) acquires 7 Cups at ~5x revenue (~$182M), delivering roughly 90% upside versus an estimated ~$90M current valuation anchored at 2.5x revenue. The $50B TAM growing at 27% annually makes 7 Cups a credible emotional-wellness bolt-on for enterprise payers.
Revenue grows modestly to ~$42M over 2 years, nudging estimated valuation to ~$100M, but no liquidity event materializes and common equity remains illiquid. Ongoing competition from BetterHelp and Talkspace limits pricing power and subscriber expansion, keeping paper gains near 10%.
The ghost-network therapist controversy triggers regulatory scrutiny and user attrition, while better-funded rivals accelerate market-share capture, compressing estimated valuation to ~$30-40M (~1x distressed revenue). Employee equity loses most of its value with no exit to crystallize even residual gains.
Preference Stack Risk
lowFunding Intensity
3%Total funding of $2.29M is ~2.5% of the estimated ~$90M valuation, meaning preferred liquidation preferences are negligible and would be cleared in virtually any exit above $3M.
Dilution Risk
lowWith only $2.29M raised over 13 years and no recent rounds, material external dilution is unlikely — though an undisclosed employee option pool refresh could still dilute common holders.
Secondary Liquidity
none7 Cups is unlisted with no disclosed secondary market activity, and its minimal institutional-investor profile makes it unlikely to appear on platforms like Forge or EquityZen.
Questions to Ask at the Interview
Strategic questions based on 7cups's data — designed to show you've done your homework.
- 1
“What is the board's specific plan for a liquidity event — has management received acquisition interest, and is an IPO on the roadmap within the next 3-5 years?”
- 2
“What is the current split between free listener users and paid therapy subscribers, and what is the year-over-year growth rate for paid subscription revenue?”
- 3
“What is the current 409A valuation, total fully-diluted share count, and how does my proposed strike price compare to the last preferred price from the February 2018 Series A?”
Community
Valuation Sentiment
Our model estimates -8% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.